Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review
August 2019
51
About the Report
About the Report
Bavarian Nordic AS (BAVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using poxvirus-based technology platforms including modified vaccinia ankara-bavarian nordic (MVA-BN). Its pipeline products are intended for the treatment of smallpox, prostate cancer, bladder cancer, solid tumors, chronic HPV infection, marburg and ebola infections and others. Bavarian Nordic has collaboration with US government and various institutes, to develop its product candidates for the treatment of cancer and infectious diseases. It has a presence in the US, Denmark and Germany. Bavarian Nordic is headquartered in Kvistgaard, Denmark.
Bavarian Nordic AS Key Recent Developments
Jun 25,2019: Bavarian Nordic applauds reauthorization of key U.S. biodefense programs
May 22,2019: Bavarian Nordic reports interim results for the first three months of 2019
Mar 21,2019: Bavarian Nordic announces annual report 2018
Nov 09,2018: Bavarian Nordic announces interim results for the first nine months of 2018
Nov 05,2018: APC Partners with Bavarian Nordic to Build Biologics Plant in Dublin, Ireland
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Bavarian Nordic AS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Teva Pharmaceutical Industries Ltd
Oncology Venture A/S
NeuroSearch AS
Genmab A/S
Ascendis Pharma A/S
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Bavarian Nordic A/S-Key Facts
Bavarian Nordic A/S-Key Employees
Bavarian Nordic A/S-Key Employee Biographies
Bavarian Nordic A/S-Major Products and Services
Bavarian Nordic A/S-History
Bavarian Nordic A/S-Company Statement
Bavarian Nordic A/S-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Bavarian Nordic A/S-Business Description
Geographical Segment: Canada
Performance
Geographical Segment: Other Geographic Markets
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The US
Performance
Bavarian Nordic A/S-SWOT Analysis
SWOT Analysis-Overview
Bavarian Nordic A/S-Strengths
Bavarian Nordic A/S-Weaknesses
Bavarian Nordic A/S-Opportunities
Bavarian Nordic A/S-Threats
Bavarian Nordic A/S-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences, Power Financial Deals and Alliances
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bavarian Nordic A/S, Recent Deals Summary
Section 5-Company's Recent Developments
Jun 25, 2019: Bavarian Nordic applauds reauthorization of key U.S. biodefense programs
May 22, 2019: Bavarian Nordic reports interim results for the first three months of 2019
Mar 21, 2019: Bavarian Nordic announces annual report 2018
Nov 09, 2018: Bavarian Nordic announces interim results for the first nine months of 2018
Nov 05, 2018: APC Partners with Bavarian Nordic to Build Biologics Plant in Dublin, Ireland
Nov 01, 2018: Henrik Juuel joins Bavarian Nordic as chief financial officer
Aug 16, 2018: Bavarian Nordic announces first half 2018 results
Aug 09, 2018: Bavarian Nordic granted EUR 30 million loan from The European Investment Bank
May 31, 2018: Bavarian Nordic Appoints Henrik Juuel As Chief Financial Officer
May 24, 2018: Bavarian Nordic Announces Interim Results for the First Three Months of 2018
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Bavarian Nordic A/S, Performance Chart (2014-2018)
Bavarian Nordic A/S, Ratio Charts
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Bavarian Nordic A/S, Key Facts
Bavarian Nordic A/S, Key Employees
Bavarian Nordic A/S, Key Employee Biographies
Bavarian Nordic A/S, Major Products and Services
Bavarian Nordic A/S, History
Bavarian Nordic A/S, Other Locations
Bavarian Nordic A/S, Subsidiaries
Bavarian Nordic A/S, Key Competitors
Bavarian Nordic A/S, Ratios based on current share price
Bavarian Nordic A/S, Annual Ratios
Bavarian Nordic A/S, Annual Ratios (Cont...1)
Bavarian Nordic A/S, Annual Ratios (Cont...2)
Bavarian Nordic A/S, Interim Ratios
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bavarian Nordic A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.